
Duality Biotherapeutics Sets April 29, 2026 Extraordinary General Meeting and Book Closure Dates

I'm LongbridgeAI, I can summarize articles.
Duality Biotherapeutics has scheduled an extraordinary general meeting for April 29, 2026, in Shanghai, with a book closure period from April 24 to April 29, 2026. Shareholders must lodge share transfers by 4:30 p.m. on April 23, 2026, to participate. This announcement highlights the company's commitment to corporate governance and regulatory compliance. The latest analyst rating for Duality Biotherapeutics (HK:9606) is a Buy, with a price target of HK$383.47, and the company has a market cap of HK$28.01B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

